SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE : revenue, balance sheet and financial ratios

SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE is a French company founded 20 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in DORMANS (51700), this company of category PME shows in 2025 a revenue of 2.7 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE (SIREN 487629750)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue 2 668 834 € 2 715 873 € 2 459 636 € 2 562 701 € 2 438 695 € 2 559 545 € 2 517 624 € 2 339 170 € 2 383 293 € 2 300 789 €
Net income 210 665 € 208 484 € 217 536 € 277 920 € 182 223 € 1 083 482 € 164 896 € 146 682 € 183 602 € 162 785 €
EBITDA 272 125 € 285 081 € 265 841 € 354 822 € 235 546 € 287 034 € 221 918 € 194 652 € 257 161 € 247 344 €
Net margin 7.9% 7.7% 8.8% 10.8% 7.5% 42.3% 6.5% 6.3% 7.7% 7.1%

Revenue and income statement

In 2025, SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE achieves revenue of 2.7 M€. Revenue is growing positively over 10 years (CAGR: +1.7%). Slight decline of -2% vs 2024. After deducting consumption (2.0 M€), gross margin stands at 709 k€, i.e. a rate of 27%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 272 k€, representing 10.2% of revenue. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 211 k€, i.e. 7.9% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2025) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

2 668 834 €

Gross margin (2025) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

708 593 €

EBITDA (2025) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

272 125 €

EBIT (2025) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

259 636 €

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

210 665 €

EBITDA margin (2025) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

10.2%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 5%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 86%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.4 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 8.4% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Satisfactory level allowing partial financing of growth.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

4.94%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

86.383%

Cash flow / Revenue (2025) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

8.42%

Repayment capacity (2025) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.439

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

11.8%

Solvency indicators evolution
SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE

Sector positioning

Debt ratio
4.94 2025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Excellent

In 2025, the debt ratio of SOCIETE D'EXERCICE LIBERA... (4.94) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
86.38% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Excellent +11 pts over 3 years

In 2025, the financial autonomy of SOCIETE D'EXERCICE LIBERA... (86.4%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
0.44 years 2025
2023
2024
2025
Q1: 0.51 years
Med: 2.46 years
Q3: 6.17 years
Excellent

In 2025, the repayment capacity of SOCIETE D'EXERCICE LIBERA... (0.44) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 445.94. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.1x. Danger: operating income does not cover interest charges, unsustainable situation.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

445.941

Interest coverage (2025) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

0.117

Liquidity indicators evolution
SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE

Sector positioning

Liquidity ratio
445.94 2025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Excellent

In 2025, the liquidity ratio of SOCIETE D'EXERCICE LIBERA... (445.94) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
0.12x 2025
2023
2024
2025
Q1: 0.0x
Med: 1.91x
Q3: 5.98x
Average

In 2025, the interest coverage of SOCIETE D'EXERCICE LIBERA... (0.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 3 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 33 days. Favorable situation: supplier credit is longer than customer credit by 30 days. Inventory turnover is 20 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 24 days of revenue, i.e. 175 k€ to permanently finance. Notable WCR improvement over the period (-70%), freeing up cash.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

175 156 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

3 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

33 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

20 j

WCR in days of revenue (2025) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

24 j

WCR and payment terms evolution
SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE

Positioning of SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE is estimated at 2 205 591 € (range 1 341 857€ - 3 139 839€). With an EBITDA of 272 125€, the sector multiple of 7.7x is applied. The price/revenue ratio is 0.61x (in line with sector norms). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
1341k€ 2205k€ 3139k€
2 205 591 € Range: 1 341 857€ - 3 139 839€
NAF 5 année 2025

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
272 125 € × 7.7x
Estimation 2 100 888 €
1 059 468€ - 3 058 454€
Revenue Multiple 30%
2 668 834 € × 0.61x
Estimation 1 619 533 €
1 193 137€ - 1 868 027€
Net Income Multiple 20%
210 665 € × 15.9x
Estimation 3 346 439 €
2 270 909€ - 5 251 023€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE with other companies in the same sector:

Frequently asked questions about SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE

What is the revenue of SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE ?

The revenue of SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE in 2025 is 2.7 M€.

Is SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE profitable?

Yes, SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE generated a net profit of 211 k€ in 2025.

Where is the headquarters of SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE ?

The headquarters of SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE is located in DORMANS (51700), in the department Marne.

Where to find the tax return of SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE ?

The tax return of SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE operate?

SOCIETE D'EXERCICE LIBERAL DE PHARMACIENS D'OFFICINE PHARMACIE DE LA VALLEE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.